Return to Contents in this Issue

Original Article


Lack of Association of Programmed Cell Death 1 Gene (PDCD1) Polymorphisms With Susceptibility to Chronic Urticaria in Patients With Positive Autologous Serum Skin Test


Z Brzoza,1 W Grzeszczak,2 W Trautsolt,2 D Moczulski3

1Chair and Clinical Department of Internal Diseases, Allergology and Clinical Immunology, Medical University of Silesia, Katowice, Poland
2Chair and Clinical Department of Internal Diseases, Diabetology and Nephrology, Medical University of Silesia, Katowice, Poland
3Chair and Clinical Department of Internal Diseases and Nephrodiabetology, Medical University of Łódź, Łódź, Poland

J Investig Allergol Clin Immunol 2012; Vol. 22(6): 432-436



Background: Autoimmune mechanisms play an important role in the pathophysiology of chronic urticaria (CU), and the autologous serum skin test (ASST) helps to identify patients with autoreactive CU. One of the factors involved in autoreactive mechanisms is the cell surface receptor programmed death-1 which is encoded by the programmed cell death 1 gene (PDCD1).

Objective: To investigate whether PDCD1 polymorphisms influence susceptibility to CU.

Methods: We enrolled 93 ASST-positive patients with CU and a control group consisting of 105 healthy volunteers. In all individuals, PD1.3 (7146 A/G; rs 11568821) and PD1.5 (7785 C/T; rs 2227981) polymorphisms were analyzed.

Results: No statistically significant differences were found between CU patients and controls for allele or genotype distribution. We also did not observe any association between PDCD1 genotypes and severity of urticaria or age of disease onset.

Conclusions: PD1.3 and PD1.5 polymorphisms were not proven to be implicated in susceptibility to ASST-positive CU in the Polish population. A more comprehensive analysis of the 2q33-2q37 genomic region might reveal whether variants of 1 or more of the genes in this region are involved in susceptibility to CU.

Key words
: Chronic urticaria. Polymorphism. Autologous serum skin test. ASST. PDCD1.